MediciNova, Inc.
COMBINATION OF IBUDILAST AND INTERFERON-BETA AND METHODS OF USING SAME
Last updated:
Abstract:
This disclosure is directed to methods of alleviating the negative effects of, treating, or slowing the progression of progressive multiple sclerosis in human patients using ibudilast and interferon-beta.
Status:
Application
Type:
Utility
Filling date:
8 Oct 2019
Issue date:
9 Apr 2020